SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Affleck G, Tennen H, Urrows S, Higgins P. Individual differences in the day-to-day experience of chronic pain: a prospective daily study of rheumatoid arthritis patients. Health Psychol 1991; 10: 41926.
  • 2
    Jamison RN, Brown GK. Validation of hourly pain intensity profiles with chronic pain patients. Pain 1991; 45: 1238.
  • 3
    Peters ML, Sorbi MJ, Kruise DA, Kerssens JJ, Verhaak PF, Bensing JM. Electronic diary assessment of pain, disability, and psychological adaptation in patients differing in duration of pain. Pain 2000; 84: 18192.
  • 4
    Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003; 17: 685701.
  • 5
    Williams DA, Gendreau M, Hufford MR, Groner K, Gracely RH, Clauw DJ. Pain assessment in patients with fibromyalgia syndrome: a consideration of methods for clinical trials. Clin J Pain 2004; 20: 34856.
  • 6
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 16072.
  • 7
    Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 1928.
  • 8
    Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient noncompliance with paper diaries. Br Med J 2002; 324: 11934.
  • 9
    Shiffman S. Real-time self-report of momentary states in the natural environment: computerized ecological momentary assessment. In: StoneAA, editor. The science of self-report: implications for research and practice. Mahwah (NJ): Lawrence Erlbaum Associates; 2000. p. 27796.
  • 10
    Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Riberio S, Gracely RH, et al. The efficacy of milnacipran in fibromyalgia. J Rheumatol. In press.
  • 11
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 16072.
  • 12
    Gracely RH, Kwilosz DM. The descriptor differential scale: applying psychophysical principles to clinical pain assessment. Pain 1988; 35: 27988.
  • 13
    Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004; 19 Suppl 1: S2735.
  • 14
    Thompson D, Lettich L, Takeshita J. Fibromyalgia: an overview. Curr Psychiatry Rep 2003; 5: 2117.
  • 15
    Yunus MB. Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med 2002; 5: 427.
  • 16
    Hapidou EG, Rollman GB. Menstrual cycle modulation of tender points. Pain 1998; 77: 15161.